IL53013A - 1-phehethylamino-2-hydroxy-3-pyridyloxy-(or pyrazinyloxy) propanes,their production and pharmaceutical compositions containing them - Google Patents

1-phehethylamino-2-hydroxy-3-pyridyloxy-(or pyrazinyloxy) propanes,their production and pharmaceutical compositions containing them

Info

Publication number
IL53013A
IL53013A IL53013A IL5301377A IL53013A IL 53013 A IL53013 A IL 53013A IL 53013 A IL53013 A IL 53013A IL 5301377 A IL5301377 A IL 5301377A IL 53013 A IL53013 A IL 53013A
Authority
IL
Israel
Prior art keywords
phehethylamino
pyrazinyloxy
propanes
pyridyloxy
hydroxy
Prior art date
Application number
IL53013A
Other languages
English (en)
Other versions
IL53013A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL53013A0 publication Critical patent/IL53013A0/xx
Publication of IL53013A publication Critical patent/IL53013A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL53013A 1976-10-05 1977-09-28 1-phehethylamino-2-hydroxy-3-pyridyloxy-(or pyrazinyloxy) propanes,their production and pharmaceutical compositions containing them IL53013A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1263576A CH607585A5 (en) 1976-10-05 1976-10-05 Process for the preparation of 2-[3'-(2-(3,4-dimethoxy-phenyl)ethylamino)-2'-hydroxypropoxy]-3-cyanop yridine

Publications (2)

Publication Number Publication Date
IL53013A0 IL53013A0 (en) 1977-11-30
IL53013A true IL53013A (en) 1981-09-13

Family

ID=4384944

Family Applications (1)

Application Number Title Priority Date Filing Date
IL53013A IL53013A (en) 1976-10-05 1977-09-28 1-phehethylamino-2-hydroxy-3-pyridyloxy-(or pyrazinyloxy) propanes,their production and pharmaceutical compositions containing them

Country Status (21)

Country Link
JP (1) JPS5350177A (ja)
AT (1) AT358037B (ja)
AU (1) AU514676B2 (ja)
BE (1) BE858867A (ja)
CA (1) CA1105021A (ja)
CH (1) CH607585A5 (ja)
DE (1) DE2740678A1 (ja)
DK (1) DK402877A (ja)
ES (1) ES462389A1 (ja)
FI (1) FI772681A (ja)
FR (1) FR2367065A1 (ja)
GB (1) GB1591723A (ja)
GR (1) GR71677B (ja)
IE (1) IE45692B1 (ja)
IL (1) IL53013A (ja)
NL (1) NL7710394A (ja)
NO (1) NO773125L (ja)
NZ (1) NZ185267A (ja)
PT (1) PT67048B (ja)
SE (1) SE7710250L (ja)
ZA (1) ZA775698B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208416A (en) * 1978-06-27 1980-06-17 Merck & Co., Inc. N-Aralkyl containing cyanopyridines
DK267779A (da) * 1978-06-27 1979-12-28 Merck & Co Inc Fr&mgangsmaade til fremstilling af n-aralkylamino-propoxycyanopyridiner
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines
GB8510146D0 (en) * 1985-04-20 1985-05-30 Smith Kline French Lab Chemical compounds & processes
DE3776011D1 (de) * 1986-06-30 1992-02-27 Toyo Jozo Kk 2-substituierte alkoxy-3-substituierte pyrazine.
WO2001036412A1 (en) * 1999-11-15 2001-05-25 Eli Lilly And Company Process for the preparation of aryloxy propanolamines

Also Published As

Publication number Publication date
BE858867A (fr) 1978-03-20
GR71677B (ja) 1983-06-21
AU2912577A (en) 1979-04-05
ATA648777A (de) 1980-01-15
FR2367065A1 (fr) 1978-05-05
ES462389A1 (es) 1978-07-01
FR2367065B1 (ja) 1980-10-10
NZ185267A (en) 1979-07-11
IE45692L (en) 1978-04-05
PT67048B (de) 1979-02-16
NO773125L (no) 1978-04-06
CA1105021A (en) 1981-07-14
CH607585A5 (en) 1978-09-15
DE2740678A1 (de) 1978-04-06
NL7710394A (nl) 1978-04-07
IE45692B1 (en) 1982-10-20
ZA775698B (en) 1978-05-30
SE7710250L (sv) 1978-04-06
FI772681A (fi) 1978-04-06
AT358037B (de) 1980-08-11
GB1591723A (en) 1981-06-24
JPS5350177A (en) 1978-05-08
AU514676B2 (en) 1981-02-19
DK402877A (da) 1978-04-06
IL53013A0 (en) 1977-11-30
PT67048A (de) 1977-10-01

Similar Documents

Publication Publication Date Title
IL51076A (en) Glucosamine-3-alkanoyl-dipeptides, their manufacture and ppharmaceutical compositions containing them
IL55382A (en) Propenylamines,their production and pharmaceutical compositions containing them
IL50011A (en) N-substituted3-trifuloromethyl-phenyl-n-benzoyl ureas,their preparation and insecticidal compositions containing the
IL51945A (en) Substituted n-cinnamyl-n-naphthylmethyl amines,their production and pharmaceutical compositions containing them
IL51840A0 (en) Trans-hexahydro-pyrido-indoles their production and pharmaceutical compositions containing them
IL60037A (en) Pyrazinobenzodiazepines,their production and pharmaceutical compositions containing them
IL50091A (en) 4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them
IL58415A (en) Substituted octahydro-7-phenylquinolizines,their manufacture and pharmaceutical compositions containing them
IL52615A0 (en) Novel 1,5-disubstituted-2-pyrrolidones,their production and pharmaceutical compositions containing them
IL55207A0 (en) Novel benzodiazepine-diones,their production and pharmaceutical compositions containing them
IL53332A (en) 3-fluoro-6-piperazino-morphanthridine derivatives,their production and pharmaceutical compositions containing them
IL53013A (en) 1-phehethylamino-2-hydroxy-3-pyridyloxy-(or pyrazinyloxy) propanes,their production and pharmaceutical compositions containing them
IL55018A0 (en) Novel benzylpyrimidines, their manufacture and pharmaceutical compositions containing them
IL54105A0 (en) Novel benzylpyrimidines, their production and pharmaceutical compositions containing them
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
IL60733A (en) 1-substituted-pyrrolidinones,their manufacture and pharmaceutical compositions containing them
IL61773A0 (en) Pyrrolobenzotriazepines,their production and pharmaceutical compositions containing them
IL55869A (en) 2,4-diamino-5-benzylpyrimidines,their manufacture and pharmaceutical compositions containing them
IL56696A (en) N1-glucofuranosid-6-yl-n3-nitroso-ureas,their production and pharmaceutical compositions containing them
IL49124A0 (en) Novel d-homosteroids,their manufacture and pharmaceutical compositions containing them
IL48937A0 (en) New 13-ethinyl-steroids,their manufacture and pharmaceutical compositions containing them
IL54508A0 (en) Novel d-homopregnanes, their manufacture and pharmaceutical compositions containing them
IL54598A0 (en) Novel benzylpyrimidines, their manufacture and pharmaceutiical compositions containing them
NZ183993A (en) 2-amino-isothioureidobenzenes, and anthelminic and fungisidal compositions containing them
IL51833A0 (en) Novel d-homosteroids their manufacture and pharmaceutical compositions containing them